TMCnet News
Bellerophon to Present at Two September Investor ConferencesWARREN, N.J., Sept. 14, 2020 (GLOBE NEWSWIRE) -- Bellerophon Therapeutics, Inc. (Nasdaq: BLPH) (“Bellerophon” or the “Company”), a clinical-stage biotherapeutics company focused on developing treatments for cardiopulmonary and infectious diseases, announced today that Fabian Tenenbaum, Chief Executive Officer, will present at two investor conferences in September: H.C. Wainwright 22nd Annual Global Investment Conference and Cantor Fitzgerald Virtual Global Healthcare Conference. H.C. Wainwright 22nd Annual Global Investment Conference
Cantor Fitzgerald Virtual Global Healthcare Conference
About Bellerophon
|